Shandong Realcan Pharmaceutical Co Ltd (002589) — Financial Flexibility Index
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of CN¥6.75 Million (operating CF CN¥-15.60 Million minus capex CN¥22.35 Million) represents 0% of total liabilities (CN¥9.87 Billion). Check how aggressively does Shandong Realcan Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Realcan Pharmaceutical Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Shandong Realcan Pharmaceutical Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see Shandong Realcan Pharmaceutical Co Ltd cash flow conversion.
Annual Financial Flexibility Index for Shandong Realcan Pharmaceutical Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Shandong Realcan Pharmaceutical Co Ltd. Explore Shandong Realcan Pharmaceutical Co Ltd (002589) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | CN¥40.58 Million | CN¥13.76 Million | CN¥8.95 Billion | ▼ -82.8% |
| 2024 | 0.03x | CN¥271.97 Million | CN¥160.44 Million | CN¥10.32 Billion | ▼ -23.4% |
| 2023 | 0.03x | CN¥380.85 Million | CN¥82.47 Million | CN¥11.07 Billion | ▼ -37.7% |
| 2022 | 0.06x | CN¥694.04 Million | CN¥523.07 Million | CN¥12.58 Billion | ▲ +1.9% |
| 2021 | 0.05x | CN¥904.04 Million | CN¥442.95 Million | CN¥16.70 Billion | ▲ +27.3% |
| 2020 | 0.04x | CN¥920.35 Million | CN¥414.96 Million | CN¥21.65 Billion | ▼ -68.8% |
| 2019 | 0.14x | CN¥3.03 Billion | CN¥2.09 Billion | CN¥22.21 Billion | ▲ +697.0% |
| 2018 | 0.02x | CN¥402.66 Million | CN¥-201.66 Million | CN¥23.53 Billion | ▲ +114.5% |
| 2017 | -0.12x | CN¥-2.04 Billion | CN¥-2.42 Billion | CN¥17.31 Billion | ▲ +33.4% |
| 2016 | -0.18x | CN¥-1.44 Billion | CN¥-1.76 Billion | CN¥8.15 Billion | ▼ -170.4% |
| 2015 | -0.07x | CN¥-356.80 Million | CN¥-466.26 Million | CN¥5.46 Billion | ▼ -1383.3% |
| 2014 | 0.01x | CN¥19.63 Million | CN¥-163.62 Million | CN¥3.85 Billion | ▲ +111.8% |
| 2013 | -0.04x | CN¥-121.36 Million | CN¥-274.46 Million | CN¥2.80 Billion | ▼ -63.7% |
| 2012 | -0.03x | CN¥-58.27 Million | CN¥-170.52 Million | CN¥2.20 Billion | ▲ +91.7% |
| 2011 | -0.32x | CN¥-446.44 Million | CN¥-475.03 Million | CN¥1.40 Billion | ▼ -448.4% |
| 2010 | 0.09x | CN¥108.28 Million | CN¥70.56 Million | CN¥1.18 Billion | ▼ -8.6% |
| 2009 | 0.10x | CN¥80.62 Million | CN¥61.38 Million | CN¥805.78 Million | ▲ +419.2% |
| 2008 | -0.03x | CN¥-18.92 Million | CN¥-49.88 Million | CN¥603.64 Million | — |